BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31859962)

  • 21. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
    Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study.
    Ito A; Ito I; Inoue D; Marumo S; Ueda T; Nakagawa H; Taki M; Nakagawa A; Tatsumi S; Nishimura T; Shiota T; Ishida T
    Int J Infect Dis; 2020 Mar; 92():228-233. PubMed ID: 31981766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of serum C-reactive protein measurements in the first 2 days on the 30-day mortality in hospitalized patients with severe community-acquired pneumonia: a cohort study.
    Nseir W; Farah R; Mograbi J; Makhoul N
    J Crit Care; 2013 Jun; 28(3):291-5. PubMed ID: 23159134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
    Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
    Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.
    Thiem U; Niklaus D; Sehlhoff B; Stückle C; Heppner HJ; Endres HG; Pientka L
    Age Ageing; 2009 Nov; 38(6):693-7. PubMed ID: 19729453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia.
    Claessens YE; Mathevon T; Kierzek G; Grabar S; Jegou D; Batard E; Loyer C; Davido A; Hausfater P; Robert H; Lavagna-Perez L; Bernot B; Plaisance P; Leroy C; Renaud B
    Intensive Care Med; 2010 May; 36(5):799-809. PubMed ID: 20232049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of plasma human β-defensin 2 level on short-term clinical outcomes in patients with community-acquired pneumonia: a preliminary study.
    Liu S; He LR; Wang W; Wang GH; He ZY
    Respir Care; 2013 Apr; 58(4):655-61. PubMed ID: 23051183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
    Wang Y; Zhang S; Li L; Xie J
    Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia.
    Ortqvist A; Hedlund J; Wretlind B; Carlström A; Kalin M
    Scand J Infect Dis; 1995; 27(5):457-62. PubMed ID: 8588135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is elevated red cell distribution width a prognostic predictor in adult patients with community acquired pneumonia?
    Braun E; Kheir J; Mashiach T; Naffaa M; Azzam ZS
    BMC Infect Dis; 2014 Mar; 14():129. PubMed ID: 24597687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein. A clinical marker in community-acquired pneumonia.
    Smith RP; Lipworth BJ; Cree IA; Spiers EM; Winter JH
    Chest; 1995 Nov; 108(5):1288-91. PubMed ID: 7587431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma lipid profiling for the prognosis of 90-day mortality, in-hospital mortality, ICU admission, and severity in bacterial community-acquired pneumonia (CAP).
    Banoei MM; Vogel HJ; Weljie AM; Yende S; Angus DC; Winston BW
    Crit Care; 2020 Jul; 24(1):461. PubMed ID: 32718333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in Red Cell Distribution Width During Hospitalization for Community-Acquired Pneumonia: Clinical Characteristics and Prognostic Significance.
    Gorelik O; Izhakian S; Barchel D; Almoznino-Sarafian D; Tzur I; Swarka M; Beberashvili I; Feldman L; Cohen N; Shteinshnaider M
    Lung; 2016 Dec; 194(6):985-995. PubMed ID: 27650510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rise in mean platelet volume during hospitalization for community-acquired pneumonia predicts poor prognosis: a retrospective observational cohort study.
    Gorelik O; Tzur I; Barchel D; Almoznino-Sarafian D; Swarka M; Beberashvili I; Feldman L; Cohen N; Izhakian S
    BMC Pulm Med; 2017 Oct; 17(1):137. PubMed ID: 29084523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated Red Blood Cell Distribution Width Combined White Blood Cell in Peripheral Blood Routine Have a Better Sensitivity than CURB-65 Scores in Predicting ICU Admission and Mortality in Adult Community-Acquired Pneumonia Patients.
    Ge YL; Liu CH; Rana MA; Zhu XY; Wang N; Xu J; Su CS; Li HL; Li ZZ; Hassan RA; Li HL; Zhang HF; Zhang X; Yu HL; Zhang JB; Fu AS; Wang HY
    Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of serial neutrophil-to-lymphocyte ratio measurements in hospitalized community-acquired pneumonia.
    Lee H; Kim I; Kang BH; Um SJ
    PLoS One; 2021; 16(4):e0250067. PubMed ID: 33857241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of hypercapnia on admission with increased length of hospital stay and severity in patients admitted with community-acquired pneumonia: a prospective observational study from Pakistan.
    Iqbal N; Irfan M; Zubairi ABS; Awan S; Khan JA
    BMJ Open; 2017 Jun; 7(6):e013924. PubMed ID: 28619767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma kallistatin levels in patients with severe community-acquired pneumonia.
    Lin WC; Lu SL; Lin CF; Chen CW; Chao L; Chao J; Lin YS
    Crit Care; 2013 Feb; 17(1):R27. PubMed ID: 23394256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission.
    Liapikou A; Ferrer M; Polverino E; Balasso V; Esperatti M; Piñer R; Mensa J; Luque N; Ewig S; Menendez R; Niederman MS; Torres A
    Clin Infect Dis; 2009 Feb; 48(4):377-85. PubMed ID: 19140759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.